Revised SPC: Vibramycin-D (doxycycline) Dispersible Tablets 100mg
SPC updated with an addition of a warning regarding risk of exacerbating systemic lupus erythematous and undesirable effects of visual disturbances and link to cranial hypertension.
Source:
electronic Medicines compendium